Nitisinone for the treatment of oculocutaneous / ocular albinism and to increase pigmentation

• 1. 用于治疗眼的新血管发生病症的包含索拉菲尼的眼科药物组合物 [P] . 中国专利： CN102164600A . 2011-08-24
• 2. 用于治疗癌症的曲美替尼、帕尼单抗和达拉菲尼组合 [P] . 中国专利： CN106029074A . 2016-10-12
• 3. NITISINONE FOR TREATMENT OF OCULOCUTANEOUS/OCULAR ALBINISM AND FOR INCREASING PIGMENTATION [P] . CA2791245C . 2019-01-15

  机译： NITISINONE用于治疗眼球/眼白化病和增加色素沉着

• 4. Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation [P] . 美国专利： US9364448B2 . 2016-06-14

  机译： Nitisinone用于治疗眼皮肤白化病和增加色素沉着

• 5. NITISINONE FOR TREATMENT OF OCULOCUTANEOUS/OCULAR ALBINISM AND FOR INCREASING PIGMENTATION [P] . 欧洲知识产权局专利： EP2538936B1 . 2014-12-24

  机译： NITISINONE用于治疗眼球/眼白化病和增加色素沉着

• 1. Increased resistance of drought by Trichoderma harzianum fungal treatment correlates with increased secondary metabolites and proline content [J] . Mona S. Alwhibi, Abeer Hashem12, Elsayed Fathi Abd_Allah, 农业科学学报：英文版 . 2017,第008期
• 2. Increased resistance of drought by Trichoderma harzianum fungal treatment correlates with increased secondary metabolites and proline content [J] . Mona S.Alwhibi, Abeer Hashem, Elsayed Fathi Abd_Allah, 农业科学学报（英文版） . 2017,第008期
• 3. Topical delivery of nerve growth factor for treatment of ocular and brain disorders [J] . Gemma Eftimiadi, Marzia Soligo, Luigi Manni, 中国神经再生研究（英文版） . 2021,第009期
• 4. Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3 [J] . Onojafe Ighovie F., Megan Lucyanne H., Melch Madeline G., Investigative ophthalmology & visual science . 2018,第12期
• 5. Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3 [J] . Ighovie F. Onojafe, Lucyanne H. Megan, Madeline G. Melch, Investigative ophthalmology & visual science . 2018,第12期
• 6. Biology and genetics of oculocutaneous albinism and vitiligo - Common pigmentation disorders in southern Africa [J] . MangaP., KerrR., RamsayM., South African medical journal: Suid-Afrikaanse tydskrif vir geneeskunde . 2013,第12期
• 7. INCREASED PHOTOBIOREACTOR PRODUCTIVITY USING ALGAE WITH LOW PIGMENTATION: A LIGHT TRANSFER PERSPECTIVE [C] . Thomas E. Murphy, Halil Berberoglu ASME International Mechanical Engineering Congress and Exposition . 2012
• 8. Molecular Basis of Tyrosinase-negative Oculocutaneous Albinism [D] . 武田 篤 1992
• 9. Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism [O] . Ighovie F. Onojafe, David R. Adams, Dimitre R. Simeonov, 2011
• 10. Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism [O] . Onojafe, Ighovie F., Adams, David R., Simeonov, Dimitre R., 2011

• 1. Correlation of Macular Thickness, Multifocal ERG with Visual Acuity in Oculocutaneous Albinism (OCA) [J] . Jitendra Jethani ,Monika Jethani ,Sugnesh Parmar . 健康（英文） . 2014,第16期
• 2. RACIAL DIFFERENCES OF OPTIC DISC TOPOGRAPHY IN OCULAR HYPERTENSIVE EYES: RESULTS FROM THE CONFOCAL SCANNING LASER OPHTHALMOSCOPY ANCILLARY STUDY TO THE OCULAR HYPERTENSION TREATMENT STUDY [J] . . 国际眼科杂志 . 2003,第001期
• 3. 新型显影剂—4-甲基菲尼酮(菲尼酮B) [C] . 沈月琴 . 第四次全国照相有机物研讨会 . 1999
• 4. 原发性开角型青光眼和眼皮肤白化病1型致病基因的研究 [A] . 刘静 . 2008